Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

OLOPATADINE HCL

Form:

14 of 14 products shown

All products: not a benefit

Other products in the same Health Canada class (S01GX) — coverage varies; not interchangeable

  • Cromoglycate (Cromolyn Eye Drops): general benefit, Not a benefit
  • Ketotifen (Zaditor): not a benefit

Mint-Olopatadine · DIN 02422727 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Olopatadine · DIN 02422727 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2014-11-27 Health Canada: Marketed since 2014-07-29 · brand MINT-OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90739 · Verify on the e-Formulary ↗ (DIN 02422727)

Source record
DIN 02422727: Mint-Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id MIN Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02422727 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90739
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Co Olopatadine 0.1% · DIN 02403986 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Olopatadine · DIN 02521172 · not recorded Patanol · DIN 02233143 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02422727
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Olopatadine · DIN 02521172 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Olopatadine · DIN 02521172 Manufacturer: Sanis Health Inc.; listing date 2022-05-31 Health Canada: Marketed since 2022-07-13 · brand OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101039 · Verify on the e-Formulary ↗ (DIN 02521172)

Source record
DIN 02521172: Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id SAI Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02521172 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=101039
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Co Olopatadine 0.1% · DIN 02403986 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Patanol · DIN 02233143 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02521172
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Patanol · DIN 02233143 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Patanol · DIN 02233143 Manufacturer: Novartis Pharma Canada Inc.; listing date 2013-01-29 Health Canada: Marketed since 2018-06-13 · brand PATANOL · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Patanol: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=53275 · Verify on the e-Formulary ↗ (DIN 02233143)

Source record
DIN 02233143: Patanol Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id NOV Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02233143 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=53275
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Co Olopatadine 0.1% · DIN 02403986 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Olopatadine · DIN 02521172 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: resolved shortage (ended 2018-06-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02233143
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Sandoz Olopatadine · DIN 02358913 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Olopatadine · DIN 02358913 Manufacturer: Sandoz Canada Inc.; listing date 2013-04-30 Health Canada: Marketed since 2013-02-04 · brand SANDOZ OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84395 · Verify on the e-Formulary ↗ (DIN 02358913)

Source record
DIN 02358913: Sandoz Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id SDZ Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02358913 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84395
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Co Olopatadine 0.1% · DIN 02403986 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Olopatadine · DIN 02521172 · not recorded Patanol · DIN 02233143 · not recorded
Shortage status: resolved shortage (ended 2021-12-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02358913
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Mint-Olopatadine 0.2% · DIN 02508605 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Mint-Olopatadine 0.2% · DIN 02508605 Manufacturer: Mint Pharmaceuticals Inc.; listing date 2022-03-31 Health Canada: Marketed since 2021-12-17 · brand MINT-OLOPATADINE 0.2% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Mint pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99796 · Verify on the e-Formulary ↗ (DIN 02508605)

Source record
DIN 02508605: Mint-Olopatadine 0.2% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id MIN Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02508605 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=99796
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Apo-Olopatadine · DIN 02402823 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Pataday · DIN 02362171 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02508605
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Olopatadine 0.2% · DIN 02541653 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Olopatadine 0.2% · DIN 02541653 Manufacturer: Sanis Health Inc.; listing date 2024-05-31 Health Canada: Marketed since 2024-04-08 · brand OLOPATADINE 0.2% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103030 · Verify on the e-Formulary ↗ (DIN 02541653)

Source record
DIN 02541653: Olopatadine 0.2% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id SAI Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02541653 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103030
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Apo-Olopatadine · DIN 02402823 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Pataday · DIN 02362171 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: resolved shortage (ended 2025-12-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02541653
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Pataday · DIN 02362171 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Pataday · DIN 02362171 Manufacturer: Novartis Pharma Canada Inc.; listing date 2014-05-29 Health Canada: Marketed since 2018-05-09 · brand PATADAY · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Novartis pharmaceuticals canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Pataday: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84721 · Verify on the e-Formulary ↗ (DIN 02362171)

Source record
DIN 02362171: Pataday Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id NOV Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02362171 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84721
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Apo-Olopatadine · DIN 02402823 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: resolved shortage (ended 2025-10-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02362171
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Sandoz Olopatadine 0.2% · DIN 02420171 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Sandoz Olopatadine 0.2% · DIN 02420171 Manufacturer: Sandoz Canada Inc.; listing date 2014-06-26 Health Canada: Marketed since 2014-02-24 · brand SANDOZ OLOPATADINE 0.2% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Sandoz canada incorporated · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90478 · Verify on the e-Formulary ↗ (DIN 02420171)

Source record
DIN 02420171: Sandoz Olopatadine 0.2% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id SDZ Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02420171 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90478
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Apo-Olopatadine · DIN 02402823 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Pataday · DIN 02362171 · not recorded
Shortage status: resolved shortage (ended 2026-08-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02420171
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Olopatadine · DIN 02305054 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitDormant since 2020-08-04 · checked 2026-09-02 · What does dormant mean?
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Olopatadine · DIN 02305054 Manufacturer: Apotex Inc.; listing date 2013-01-29 Health Canada: Dormant since 2020-08-04 · brand APO-OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 % · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79042 · Verify on the e-Formulary ↗ (DIN 02305054)

Source record
DIN 02305054: Apo-Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id APX Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02305054 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79042
Interchangeable products
Co Olopatadine 0.1% · DIN 02403986 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Olopatadine · DIN 02521172 · not recorded Patanol · DIN 02233143 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: active shortage (reported 2020-06-01, last updated 2020-06-04) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02305054
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2020-08-04 — choose a marketed DIN from the same-category list.

Jamp-Olopatadine · DIN 02458411 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefitDormant since 2025-07-31 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Olopatadine · DIN 02458411 Manufacturer: Jamp Pharma Corporation; listing date 2017-03-28 Health Canada: Dormant since 2025-07-31 · brand JAMP-OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94555 · Verify on the e-Formulary ↗ (DIN 02458411)

Source record
DIN 02458411: Jamp-Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id JPC Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02458411 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=94555
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Co Olopatadine 0.1% · DIN 02403986 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Olopatadine · DIN 02521172 · not recorded Patanol · DIN 02233143 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: active shortage (reported 2025-08-07, estimated to end 2026-03-31, last updated 2025-09-23); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02458411
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2025-07-31 — choose a marketed DIN from the same-category list.

Apo-Olopatadine · DIN 02402823 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitDormant since 2025-04-03 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Olopatadine · DIN 02402823 Manufacturer: Apotex Inc.; listing date 2014-05-29 Health Canada: Dormant since 2025-04-03 · brand APO-OLOPATADINE · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88766 · Verify on the e-Formulary ↗ (DIN 02402823)

Source record
DIN 02402823: Apo-Olopatadine Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id APX Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02402823 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88766
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Pataday · DIN 02362171 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: active shortage (reported 2024-03-26, last updated 2024-03-27) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02402823
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2025-04-03 — choose a marketed DIN from the same-category list.

Jamp Olopatadine 0.2% · DIN 02560976 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefitApproved · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp Olopatadine 0.2% · DIN 02560976 Manufacturer: Jamp Pharma Corporation; listing date 2026-04-30 Health Canada: Approved since 2025-09-10 · brand JAMP OLOPATADINE 0.2% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE HYDROCHLORIDE 0.2 %/W/V · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106398 · Verify on the e-Formulary ↗ (DIN 02560976)

Source record
DIN 02560976: Jamp Olopatadine 0.2% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id JPC Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02560976 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106398
Interchangeable products
Act Olopatadine 0.2% · DIN 02404095 · not recorded Apo-Olopatadine · DIN 02402823 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Pataday · DIN 02362171 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02560976
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Approved since 2025-09-10 — choose a marketed DIN from the same-category list.

Co Olopatadine 0.1% · DIN 02403986 · 0.1% · Oph Sol-5mL Pk

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.Discontinued 2021-07-30 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Co Olopatadine 0.1% · DIN 02403986 Manufacturer: Cobalt Pharmaceuticals Company; listing date 2014-02-27 Health Canada: Cancelled post market since 2021-07-30 · brand ACT OLOPATADINE 0.1% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.1 %/W/V · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88874 · Verify on the e-Formulary ↗ (DIN 02403986)

Source record
DIN 02403986: Co Olopatadine 0.1% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600094; group id 635; item number 1606; lccId None; manufacturer id COB Source form: Oph Sol-5mL Pk; strength: 0.1% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02403986 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88874
Interchangeable products
Apo-Olopatadine · DIN 02305054 · not recorded Jamp-Olopatadine · DIN 02458411 · not recorded Mint-Olopatadine · DIN 02422727 · not recorded Olopatadine · DIN 02521172 · not recorded Patanol · DIN 02233143 · not recorded Sandoz Olopatadine · DIN 02358913 · not recorded
Shortage status: active shortage (reported 2018-09-01, last updated 2018-10-23) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02403986
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.

Act Olopatadine 0.2% · DIN 02404095 · 0.2% · Oph Sol-2.5mL Pk

Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.Discontinued 2021-07-30 · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Act Olopatadine 0.2% · DIN 02404095 Manufacturer: Actavis Pharma Company; listing date 2014-05-29 Health Canada: Cancelled post market since 2021-07-30 · brand ACT OLOPATADINE 0.2% · ATC S01GX09 OLOPATADINE · form Solution · route Ophthalmic · ingredients OLOPATADINE (OLOPATADINE HYDROCHLORIDE) 0.2 %/W/V · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88887 · Verify on the e-Formulary ↗ (DIN 02404095)

Source record
DIN 02404095: Act Olopatadine 0.2% Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 523600137; group id 635; item number 1605; lccId None; manufacturer id ACV Source form: Oph Sol-2.5mL Pk; strength: 0.2% Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $26.1300; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02404095 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=88887
Interchangeable products
Apo-Olopatadine · DIN 02402823 · not recorded Jamp Olopatadine 0.2% · DIN 02560976 · not recorded Mint-Olopatadine 0.2% · DIN 02508605 · not recorded Olopatadine 0.2% · DIN 02541653 · not recorded Pataday · DIN 02362171 · not recorded Sandoz Olopatadine 0.2% · DIN 02420171 · not recorded
Shortage status: active shortage (reported 2018-09-01, last updated 2018-10-23) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02404095
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (52:36 Other Eye, Ear, Nose and Throat Agents) and how they are covered

Matched class: 52:36 Other Eye, Ear, Nose and Throat Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BETAXOLOL HCL, DICLOFENAC SODIUM, LEVOBUNOLOL HCL Some products covered without a code (check the product listing): ACETAZOLAMIDE, METHAZOLAMIDE, SODIUM CROMOGLYCATE, TIMOLOL MALEATE 52:36 Other Eye, Ear, Nose and Throat Agents

SODIUM CROMOGLYCATE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 2% · Oph Sol

KETOTIFEN

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.25mg/mL · Oph Sol-5mL Pk

ACETAZOLAMIDE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 250mg · Tab

BETAXOLOL HCL

· 1 products · General benefit · strengths: 0.25% · Oph Susp

DICLOFENAC SODIUM

· 6 products · General benefit · strengths: 0.1% · Oph Sol

LEVOBUNOLOL HCL

· 1 products · General benefit · strengths: 0.5% · Oph Sol

METHAZOLAMIDE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 50mg · Tab

TIMOLOL MALEATE

· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 0.25%, 0.5% · Oph Gellan Sol, Oph Sol

AFLIBERCEPT

· 6 products · Limited Use, codes 729, 730, 731 (4), Limited Use, codes 694, 695 (2) · strengths: 2mg/0.05mL, 8mg/0.07mL · Inj Sol-0.05mL Pref Syr (Preservative-Free), Inj Sol-0.07mL Pref Syr, Inj Sol-0.07mL Vial Pk, Sol for Intravitreal Inj-0.05mL Vial Pk

BIMATOPROST

· 8 products · Listed, not a benefit (1), Limited Use, codes 171, 172, 387 (7) · strengths: 0.03%, 0.01% · Oph Sol, Oph Sol-5mL Pk, Oph Sol-7.5mL Pk

BRIMONIDINE

· 7 products · Limited Use, codes 171, 172, 387 · strengths: 0.15%, 0.2% · Oph Sol

BRIMONIDINE TARTRATE & TIMOLOL MALEATE

· 3 products · Limited Use, codes 310, 393 · strengths: 0.2% & 0.5% · Oph Sol-10mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:36 and 20 more
Full class listing Related classes: 52:04 Anti-Infectives, 52:08 Anti-Inflammatory Agents, 52:16 Local Anesthetics, 52:20 Miotics, 52:24 Mydriatics, 52:32 Vasoconstrictors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: allergic conjunctivitis
From Health Canada product monographs; label wording only, not a treatment recommendation. Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ. No displayed matched alternative is a general benefit. KETOTIFEN · Off-Formulary Interchangeable, not an ODB benefit • treatment of allergic conjunctivitis. PM: https://pdf.hres.ca/dpd_pm/00076212.PDF; date February 23, 2012; DIN 02242324; fetched 2026-09-10 Product monograph Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE PATANOL® (olopatadine hydrochloride ophthalmic solution) is indicated for the treatment of allergic conjunctivitis. Geriatrics: No overall difference in safety has been observed between elderly and other adult patients. Pediatrics (3 – 16 years of age): PATANOL administered three times a day for six weeks was shown to be safe and well-tolerated in subjects who were ages 3 years and older. https://pdf.hres.ca/dpd_pm/00044108.PDF PM date: March 2, 2018 Source product: PATANOL; DIN 02233143; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Apo-Olopatadine · DIN 02305054 Shortage status: active shortage (reported 2020-06-01, last updated 2020-06-04) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02305054

Check this DIN again

Jamp-Olopatadine · DIN 02458411 Shortage status: active shortage (reported 2025-08-07, estimated to end 2026-03-31, last updated 2025-09-23); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02458411

Check this DIN again

Apo-Olopatadine · DIN 02402823 Shortage status: active shortage (reported 2024-03-26, last updated 2024-03-27) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02402823

Check this DIN again

Co Olopatadine 0.1% · DIN 02403986 Shortage status: active shortage (reported 2018-09-01, last updated 2018-10-23) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02403986

Check this DIN again

Act Olopatadine 0.2% · DIN 02404095 Shortage status: active shortage (reported 2018-09-01, last updated 2018-10-23) — report may be stale, confirm; reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02404095

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For Mint-Olopatadine, Olopatadine, Patanol, Sandoz Olopatadine, Mint-Olopatadine 0.2%, Olopatadine 0.2%, Pataday, Sandoz Olopatadine 0.2%, Apo-Olopatadine, Jamp-Olopatadine, Jamp Olopatadine 0.2%, Co Olopatadine 0.1%, Act Olopatadine 0.2%: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026